Dion Gisele has filed 3 insider transactions across 2 companies since June 2023.
Most recent transaction: a grant/award of 30000 shares of Inhibikase Therapeutics, Inc. ($IKT) on July 16, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 16, 2024 | Inhibikase Therapeutics, Inc. | $IKT | Dion Gisele | Not found | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 6,028,210 | 9999.99% | 0.50% |
| June 30, 2023 | Inhibikase Therapeutics, Inc. | $IKT | Dion Gisele | Not found | A | Stock Option (right to buy) | 6667 | $0.00 | 6,667.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2023 | Cytek Biosciences, Inc. | $CTKB | Dion Gisele | Director | A | Stock Option (right to buy) | 30242 | $0.00 | 30,242.0000 | 138,562,111 | 9999.99% | 0.02% |